Skip to page content  Home  Recombinant DNA  Genetics, Health, and Society  Dual Use Research  Clinical Research Policy
  Genetic Testing Registry
    Genome Wide Association Studies
    SACGHS Archives
  SACGT Archives
 
SACGHS June 15-16, 2010 - Presentation Materials
Twenty Second Meeting
Washington, DC
  Breakout Webcasts  
   Morning Session (before break)
 
   Morning Session (after break)
 
   Afternoon Session (before break)
 
   Afternoon Session (after break)
 
   Morning Session (before break)
 
   Morning Session (after break)
 
   Afternoon Session (before break)
 
  Presentation Materials for June 15th  
   Overview of the Regulatory Science Initiative and Genetic Testing Registry
Kathy Hudson, Ph.D.
Chief of Staff
National Institutes of Health
 
   ONC and HITECH: An Update
David R. Hunt, MD, FACS
Medical Director, Office of Provider Adoption & Support
Office of the National Coordinator for Health IT
 
   CDC Guidelines for Good Laboratory Practices in Genetic Testing
Bin Chen, PhD, FACMG
Office of Surveillance, Epidemiology, and Laboratory Services
Centers for Disease Control and Prevention (CDC)
Atlanta, GA
 
   Whole-Genome Sequencing-Implications for Clinical Care
Charis Eng, MD, PhD, FACP
Session Co-Chair
 
   Affordable Whole-Genome Sequencing (WGS)
Paul Billings, M.D., Ph.D.
SACGHS Members
 
   Overview of WGS
Dietrich A,. Stephan,PhD
President and CEO Complete Genomics
 
   Implications of Affordable Whole Genome Sequencing: Quality and Management of WGS Data
Clifford A. Reid, Ph.D.
President and CEO, Complete genomics
 
   Preparing and Managing Whole Genome Sequence Data for the Clinical Setting
Martin G. Reese,PhD
Co-Founder, President and CEO Omicia
 
   WGS Data and Clinical Utility
W. Gregory Feero, M.D., Ph.D.
Faculty, Maine-Dartmouth Family
Practice Residency Program, Augusta, ME
Special Advisor to the Director for Genomic Medicine NHGRI, NIH
 
   Impact of Whole Genome Sequencing on the Practice of Health Care
Emily Edelman, MS, CGC
National Coalition for Health Professional Education in Genetics
 
   Ethical, Legal, and Social Issues of WGS
Richard R. Sharp, Ph.D.
Director, Bioethics Research
Cleveland Clinic
 
   Economic Value of Whole Genome Sequencing
Steven Teutsch, MD, MPH
Chief Science Officer
Los Angeles County Dept of Public Health
 
  Presentation Materials for June 16th  
   FDA Updates
Elizabeth Mansfield, Ph.D.
Office of In Vitro Diagnostic Device Evaluation and Safety
Center for Devices and Radiological Health, FDA
 
   SACGHS Session on Genomic Data Sharing
Charmaine Royal, Ph.D.
Secretary's Advisory Committee on Genetics, Health, and Society
 
   Committee Report on the Retention and Use of Residual Dried Blood Spot Specimens After Newborn Screening
R. Rodney Howell, M.D.
Chair, Secretary's Advisory Committee on Heritable Disorders in Newborns and Children
 
   Carrier Screening
Sara Copeland, MD
Workgroup on Carrier Screening
Secretary's Advisory Committee on Heritable Disorders in Newborns and Children
 
   Challenges and Opportunities in Using Newborn Screening Samples for Translational Research:A Workshop of the Institute of Medicine
Adam Berger, Ph.D.
Project Director
Roundtable on Translating Genomic-Based Research for Health
 
   SACGHS Review of SACHDNC Draft Briefing Paper on Retention and Use of Residual Dried Blood Spot Specimens After Newborn Screening
Janice V. Bach, M.S., CGC
SACGHS Steering Group Leader
 
 
none
Disclaimer | Privacy Policy | FOIA | Accessibility | Directions to OBA
none
HHS - Home Page Department of Health and Human Services   National Institutes of Health - Home Page National Institutes of Health   N I H - Office of Science Policy Office of Science Policy   USA.gov - government made easy
none
N I H - Office of Biotechnology Activities N I H - Office of Science Policy National Institutes of Health, DHHS